EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy

Yixing Wang, Jessica D Hess iD, Chen Wang, Lingzi Ma, Megan Luo, Jennifer Jossart, John J Perry, David Kwon, Zhe Wang, Xinyu Pei, Changxian Shen, Yingying Wang und 6 weitere

ACS Chemical Biology · 20.06.2025 · 20 (6) · 1258-1272

DOI: 10.1021/acschembio.5c00117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 16.05.2025. Verfasst von Yixing Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, California 91010, United States. Hauptthemen laut MEDLINE: Antineoplastic Agents, DNA Repair Enzymes, Drug Discovery, Enzyme Inhibitors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, City of Hope Integrated Drug Development Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDNA Repair EnzymesDrug DiscoveryEnzyme InhibitorsExodeoxyribonucleasesHomologous RecombinationNeoplasmsSmall Molecule LibrariesHumansCell Line, TumorDNA Breaks, Double-StrandedHigh-Throughput Screening AssaysMolecular Docking SimulationGenes, BRCA1Genes, BRCA2

Substanzen

Antineoplastic AgentsDNA Repair EnzymesEnzyme InhibitorsEXO1 protein, humanExodeoxyribonucleasesSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope, Duarte, California 91010, United States.
  • Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute, City of Hope, Duarte, California 91010, United States.
  • Department of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California 91010, United States.
  • Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, Maryland 20892, United States.

ORCID-Profile: Jessica D Hess, Binghui Shen

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • City of Hope Integrated Drug Development Venture

Zitieren

APA

Wang, Y., Hess, J. D., Wang, C., Ma, L., Luo, M., Jossart, J., Perry, J. J., Kwon, D., Wang, Z., Pei, X., Shen, C., Wang, Y., Zhou, M., Yin, H., Horne, D., Nussenzweig, A., Zheng, L., & Shen, B. (2025). Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy. ACS Chemical Biology, 20(6), 1258-1272. https://doi.org/10.1021/acschembio.5c00117

Vancouver

Wang Y, Hess JD, Wang C, Ma L, Luo M, Jossart J, et al. Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy. ACS Chemical Biology. 2025;20(6):1258-1272. doi:10.1021/acschembio.5c00117

BibTeX
@article{Wang2025,
  author = {Wang, Yixing and Hess, Jessica D and Wang, Chen and Ma, Lingzi and Luo, Megan and Jossart, Jennifer and Perry, John J and Kwon, David and Wang, Zhe and Pei, Xinyu and Shen, Changxian and Wang, Yingying and Zhou, Mian and Yin, Holly and Horne, David and Nussenzweig, André and Zheng, Li and Shen, Binghui},
  title = {Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy},
  journal = {ACS Chemical Biology},
  year = {2025},
  volume = {20},
  number = {6},
  pages = {1258--1272},
  doi = {10.1021/acschembio.5c00117}
}
Kostenlos starten →